Statistics
Publications
1
Citations
57
H-Index
1
Active since
2020
Affiliations
Johns Hopkins Medicine(Current)
Sarah Nullmeyergh is an author at Johns Hopkins Medicine specializing in glioblastoma targeted therapy, glioblastoma, and egfr inhibition.
Publications per year
2020–2020
1
1
Efficacy of osimertinib against EGFRvIII+ glioblastoma
Gustavo Chagoya, Shawn G. Kwatra, Cory Nanni et al. · Oncotarget · 2020 · 57 citations · Full text
Medicine, Oncology, Pharmacology +13
1–1 of 1